| 1 | Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials | 16.5 | 73 | Citations (PDF) |
| 2 | Evaluation and 1-year follow-up of patients presenting at a Lyme borreliosis expertise centre: a prospective cohort study with validated questionnaires | 2.6 | 2 | Citations (PDF) |
| 3 | Treatment Outcomes Among Patients With a PositiveCandidaCulture Close to Randomization Receiving Rezafungin or Caspofungin in the ReSTORE Study | 5.2 | 8 | Citations (PDF) |
| 4 | EXTENDED SURGICAL ANTIBIOTIC PROPHYLAXIS NOT SUPERIOR TO A SINGLE DOSE IN TOTAL HIP AND KNEE REVISION ARTHROPLASTY: A MULTICENTRE OPEN-LABEL RANDOMIZED CONTROLLED TRIAL | 0.0 | 0 | Citations (PDF) |
| 5 | Classical Borrelia Serology Does Not Aid in the Diagnosis of Persistent Symptoms Attributed to Lyme Borreliosis: A Retrospective Cohort Study | 2.6 | 1 | Citations (PDF) |
| 6 | P29 Outcomes by baseline pathogen and susceptibility in the ReSTORE Phase 3 trial of rezafungin once weekly compared with caspofungin once daily in patients with candidaemia and/or invasive candidiasis | 1.8 | 1 | Citations (PDF) |
| 7 | An Exaggerated Monocyte-Derived Cytokine Response to Candida Hyphae in Patients With Recurrent Vulvovaginal Candidiasis | 3.7 | 30 | Citations (PDF) |
| 8 | Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources | 6.9 | 92 | Citations (PDF) |
| 9 | Borrelia burgdorferi Is a Poor Inducer of Gamma Interferon: Amplification Induced by Interleukin-12 | 2.7 | 10 | Citations (PDF) |
| 10 | Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study | 4.2 | 46 | Citations (PDF) |
| 11 | Immunological Effects of Anti‒IL-17/12/23 Therapy in Patients with Psoriasis Complicated by Candida Infections | 2.3 | 14 | Citations (PDF) |
| 12 | 231. Outcomes by Baseline Pathogen and Susceptibility in the ReSTORE Phase 3 Trial of Rezafungin Once Weekly Compared with Caspofungin Once Daily in Patients with Candidemia and/or Invasive Candidiasis | 0.8 | 1 | Citations (PDF) |
| 13 | Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline | 5.3 | 175 | Citations (PDF) |
| 14 | EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group | 5.2 | 277 | Citations (PDF) |
| 15 | The Initial QuantiFERON-Lyme Prototype is Unsuitable for European Patients | 5.2 | 4 | Citations (PDF) |
| 16 | Expectancies as predictors of symptom improvement after antimicrobial therapy for persistent symptoms attributed to Lyme disease | 2.2 | 7 | Citations (PDF) |
| 17 | Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study | 6.9 | 68 | Citations (PDF) |
| 18 | Quality Indicators for Appropriate Outpatient Parenteral Antimicrobial Therapy in Adults: A Systematic Review and RAND-modified Delphi Procedure | 5.2 | 34 | Citations (PDF) |
| 19 | Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium | 5.2 | 2,586 | Citations (PDF) |
| 20 | Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris | 16.0 | 132 | Citations (PDF) |
| 21 | Cognitive impairments in patients with persistent symptoms attributed to Lyme disease | 2.6 | 13 | Citations (PDF) |
| 22 | A systems genomics approach identifies
SIGLEC15
as a susceptibility factor in recurrent vulvovaginal candidiasis | 12.5 | 54 | Citations (PDF) |
| 23 | Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project | 6.0 | 220 | Citations (PDF) |
| 24 | A Genome-Wide Functional Genomics Approach Identifies Susceptibility Pathways to Fungal Bloodstream Infection in Humans | 3.7 | 24 | Citations (PDF) |
| 25 | Prophylactic antibiotics reduce hospitalisations and cost in locally advanced head and neck cancer patients treated with chemoradiotherapy: A randomised phase 2 study | 4.9 | 12 | Citations (PDF) |
| 26 | Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis | 1.0 | 34 | Citations (PDF) |
| 27 | Clinical Outcome of Antibiotic Suppressive Therapy in Patients with a Prosthetic Joint Infection after Hip Replacement | 2.4 | 36 | Citations (PDF) |
| 28 | Appropriate empirical antibiotic use in the emergency department: full compliance matters! | 1.8 | 7 | Citations (PDF) |
| 29 | 18F-FDG PET/CT–Guided Treatment Duration in Patients with High-Risk Staphylococcus Aureus Bacteremia: A Proof of Principle | 5.1 | 42 | Citations (PDF) |
| 30 | Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial | 5.2 | 165 | Citations (PDF) |
| 31 | Neutrophils differentially attenuate immune response toAspergillusinfection through complement receptor 3 and induction of myeloperoxidase | 1.6 | 7 | Citations (PDF) |
| 32 | Quality of outpatient parenteral antimicrobial therapy (OPAT) care from the patient’s perspective: a qualitative study | 1.9 | 37 | Citations (PDF) |
| 33 | A survey on antimicrobial stewardship prerequisites, objectives and improvement strategies: systematic development and nationwide assessment in Dutch acute care hospitals | 3.1 | 24 | Citations (PDF) |
| 34 | Human resources required for antimicrobial stewardship teams: a Dutch consensus report | 5.3 | 32 | Citations (PDF) |
| 35 | Patient Susceptibility to Candidiasis—A Potential for Adjunctive Immunotherapy | 3.4 | 32 | Citations (PDF) |
| 36 | Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease | 2.3 | 7 | Citations (PDF) |
| 37 | Invasive candidiasis | 46.9 | 1,428 | Citations (PDF) |
| 38 | Adjuvant interferon-gamma immunotherapy in a patient with progressive cerebral Nocardia abscesses | 2.1 | 11 | Citations (PDF) |
| 39 | Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials | 3.1 | 28 | Citations (PDF) |
| 40 | Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study | 2.6 | 41 | Citations (PDF) |
| 41 | 18F-FDG PET/CT Optimizes Treatment in Staphylococcus Aureus Bacteremia and Is Associated with Reduced Mortality | 5.1 | 92 | Citations (PDF) |
| 42 | Influenza-associated Aspergillosis in Critically Ill Patients | 8.9 | 215 | Citations (PDF) |
| 43 | An electronic trigger tool to optimise intravenous to oral antibiotic switch: a controlled, interrupted time series study | 3.9 | 27 | Citations (PDF) |
| 44 | Monitoring, documenting and reporting the quality of antibiotic use in the Netherlands: a pilot study to establish a national antimicrobial stewardship registry | 2.6 | 38 | Citations (PDF) |
| 45 | An integrative genomics approach identifies novel pathways that influence candidaemia susceptibility | 2.3 | 26 | Citations (PDF) |
| 46 | Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease | 34.5 | 235 | Citations (PDF) |
| 47 | Immunologic defects in severe mucocutaneous HSV-2 infections: Response to IFN-γ therapy | 6.1 | 8 | Citations (PDF) |
| 48 | Understanding human immune function using the resources from the Human Functional Genomics Project | 33.0 | 73 | Citations (PDF) |
| 49 | Functional and Genomic Architecture of Borrelia burgdorferi -Induced Cytokine Responses in Humans | 15.1 | 58 | Citations (PDF) |
| 50 | CXCR1-mediated neutrophil degranulation and fungal killing promote
Candida
clearance and host survival | 12.5 | 79 | Citations (PDF) |
| 51 | Invasive Candidiasis | 34.5 | 52 | Citations (PDF) |
| 52 | Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis | 16.5 | 671 | Citations (PDF) |
| 53 | Association of a variable number tandem repeat in the NLRP3 gene in women with susceptibility to RVVC | 2.6 | 69 | Citations (PDF) |
| 54 | Utility of immune response-derived biomarkers in the differential diagnosis of inflammatory disorders | 2.8 | 40 | Citations (PDF) |
| 55 | The RIG-I-like helicase receptor MDA5 (IFIH1) is involved in the host defense against Candida infections | 2.6 | 81 | Citations (PDF) |
| 56 | Th17 cytokine deficiency in patients with Aspergillus skull base osteomyelitis | 2.6 | 25 | Citations (PDF) |
| 57 | Immune defence against Candida fungal infections | 53.8 | 609 | Citations (PDF) |
| 58 | Invasive Candidiasis | 34.5 | 1,242 | Citations (PDF) |
| 59 | International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus | 19.2 | 306 | Citations (PDF) |
| 60 | Adoption of a national antimicrobial guide (SWAB-ID) in the Netherlands | 2.0 | 23 | Citations (PDF) |
| 61 | The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases | 2.4 | 65 | Citations (PDF) |
| 62 | Lymeziekte: valkuilen en misverstanden | 0.0 | 0 | Citations (PDF) |
| 63 | Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia | 13.7 | 78 | Citations (PDF) |
| 64 | Antibiotic Mixing through Impacted Bone Grafts Does Not Seem Indicated in Two-Stage Cemented Hip Revisions for Septic Loosening | 1.3 | 3 | Citations (PDF) |
| 65 | Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis | 3.9 | 80 | Citations (PDF) |
| 66 | Immunotherapy | 3.3 | 27 | Citations (PDF) |
| 67 | Cytokine Production Assays Reveal Discriminatory Immune Defects in Adults with Recurrent Infections and Noninfectious Inflammation | 3.1 | 6 | Citations (PDF) |
| 68 | Role of Dectin-2 for Host Defense against Systemic Infection with Candida glabrata | 2.7 | 111 | Citations (PDF) |
| 69 | Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis | 2.3 | 23 | Citations (PDF) |
| 70 | Human TLR10 is an anti-inflammatory pattern-recognition receptor | 7.5 | 240 | Citations (PDF) |
| 71 | Role of autophagy genetic variants for the risk of Candida infections | 0.6 | 18 | Citations (PDF) |
| 72 | Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series | 2.6 | 242 | Citations (PDF) |
| 73 | Genetic susceptibility to
Candida
infections | 7.1 | 115 | Citations (PDF) |
| 74 | Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans | 13.7 | 183 | Citations (PDF) |
| 75 | Genetic Basis for Recurrent Vulvo-Vaginal Candidiasis | 2.6 | 52 | Citations (PDF) |
| 76 | An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity | 3.1 | 22 | Citations (PDF) |
| 77 | Autophagy is redundant for the host defense against systemic Candida albicans infections | 2.6 | 38 | Citations (PDF) |
| 78 | CX3CR1-dependent renal macrophage survival promotes Candida control and host survival | 10.6 | 219 | Citations (PDF) |
| 79 | Immunomodulators in Bacterial and Fungal Infections | 0.1 | 1 | Citations (PDF) |
| 80 | Proinflammatory Cytokines in the Treatment of Bacterial and Fungal Infections | 6.2 | 18 | Citations (PDF) |
| 81 | Safety and Tolerability of Voriconazole in Patients with Baseline Renal Insufficiency and Candidemia | 4.1 | 41 | Citations (PDF) |
| 82 | Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials | 5.2 | 750 | Citations (PDF) |
| 83 | Toll-like Receptor 1 Polymorphisms Increase Susceptibility to Candidemia | 3.7 | 129 | Citations (PDF) |
| 84 | Reply to Anaissie and Nucci and to Cisneros et al | 5.2 | 0 | Citations (PDF) |
| 85 | Cytokine Gene Polymorphisms and the Outcome of Invasive Candidiasis: A Prospective Cohort Study | 5.2 | 72 | Citations (PDF) |
| 86 | Metastatic Infectious Disease and Clinical Outcome in Staphylococcus aureus and Streptococcus species Bacteremia | 1.2 | 109 | Citations (PDF) |
| 87 | ESCMID
guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT) | 5.3 | 312 | Citations (PDF) |
| 88 | Candida albicans Infection Affords Protection against Reinfection via Functional Reprogramming of Monocytes | 15.1 | 1,219 | Citations (PDF) |
| 89 | Association of esophageal candidiasis and squamous cell carcinoma | 1.3 | 54 | Citations (PDF) |
| 90 | Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis | 4.0 | 90 | Citations (PDF) |
| 91 | Treatment of candidiasis: insights from host genetics | 3.8 | 8 | Citations (PDF) |
| 92 | ESCMID
guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. | 5.3 | 315 | Citations (PDF) |
| 93 | Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement | 2.8 | 47 | Citations (PDF) |
| 94 | Interplay between Candida albicans and the Mammalian Innate Host Defense | 2.7 | 227 | Citations (PDF) |
| 95 | Complement plays a central role in
C
andida albicans
‐induced cytokine production by human
PBMC
s | 3.1 | 62 | Citations (PDF) |
| 96 | Human genetic susceptibility toCandidainfections | 0.6 | 44 | Citations (PDF) |
| 97 | Adjunctive immunotherapy with recombinant cytokines for the treatment of disseminated candidiasis | 5.3 | 32 | Citations (PDF) |
| 98 | STAT1
Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis | 34.5 | 659 | Citations (PDF) |
| 99 | Early treatment of candidemia in adults: a review | 0.6 | 87 | Citations (PDF) |
| 100 | Immune Response To
Aspergillus Fumigatus
In Compromised Hosts: From Bedside To Bench | 2.0 | 16 | Citations (PDF) |
| 101 | Recognition and Blocking of Innate Immunity Cells by Candida albicans Chitin | 2.7 | 196 | Citations (PDF) |
| 102 | Inflammasome-Independent Modulation of Cytokine Response by Autophagy in Human Cells | 2.3 | 190 | Citations (PDF) |
| 103 | STAT1 Hyperphosphorylation and Defective IL12R/IL23R Signaling Underlie Defective Immunity in Autosomal Dominant Chronic Mucocutaneous Candidiasis | 2.3 | 109 | Citations (PDF) |
| 104 | TREM-1 interaction with the LPS/TLR4 receptor complex | 1.1 | 63 | Citations (PDF) |
| 105 | Genetic Variation in the Dectin-1/CARD9 Recognition Pathway and Susceptibility to Candidemia | 3.7 | 88 | Citations (PDF) |
| 106 | Borrelia species induce inflammasome activation and IL‐17 production through a caspase‐1‐dependent mechanism | 3.1 | 42 | Citations (PDF) |
| 107 | The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis | 3.1 | 142 | Citations (PDF) |
| 108 | The classical CD14++CD16− monocytes, but not the patrolling CD14+CD16+ monocytes, promote Th17 responses to Candida albicans | 3.1 | 50 | Citations (PDF) |
| 109 | Aspergillus fumigatus cell wall components differentially modulate host TLR2 and TLR4 responses | 2.4 | 101 | Citations (PDF) |
| 110 | The dectin-1/inflammasome pathway is responsible for the induction of protective T-helper 17 responses that discriminate between yeasts and hyphae ofCandida albicans | 2.9 | 182 | Citations (PDF) |
| 111 | Role of Interleukin-23 (IL-23) Receptor Signaling for IL-17 Responses in Human Lyme Disease | 2.7 | 36 | Citations (PDF) |
| 112 | Cost-Effectiveness of Routine18F-FDG PET/CT in High-Risk Patients with Gram-Positive Bacteremia | 5.1 | 88 | Citations (PDF) |
| 113 | ICU-acquired immunosuppression and the risk for secondary fungal infections | 0.6 | 65 | Citations (PDF) |
| 114 | Ocular Manifestations of Candidemia | 5.2 | 202 | Citations (PDF) |
| 115 | Variation in Genes of β-glucan Recognition Pathway and Susceptibility to Opportunistic Infections in HIV-Positive Patients | 2.1 | 7 | Citations (PDF) |
| 116 | The Y238X Stop Codon Polymorphism in the Human β-Glucan Receptor Dectin-1 and Susceptibility to Invasive Aspergillosis | 3.7 | 120 | Citations (PDF) |
| 117 | 1,25-dihydroxyvitamin D3 Modulates Cytokine Production Induced by Candida albicans: Impact of Seasonal Variation of Immune Responses | 3.7 | 72 | Citations (PDF) |
| 118 | Non-adherence to antimicrobial treatment guidelines results in more broad-spectrum but not more appropriate therapy | 2.6 | 30 | Citations (PDF) |
| 119 | 18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation | 5.5 | 53 | Citations (PDF) |
| 120 | The impact of caspase-12 on susceptibility to candidemia | 2.6 | 15 | Citations (PDF) |
| 121 | TLR1/TLR2 Heterodimers Play an Important Role in the Recognition of Borrelia Spirochetes | 2.3 | 67 | Citations (PDF) |
| 122 | Genetic Variation of Innate Immune Genes in HIV-Infected African Patients With or Without Oropharyngeal Candidiasis | 1.8 | 54 | Citations (PDF) |
| 123 | DIFFERENTIAL EFFECTS OF IL-17 PATHWAY IN DISSEMINATED CANDIDIASIS AND ZYMOSAN-INDUCED MULTIPLE ORGAN FAILURE | 2.4 | 40 | Citations (PDF) |
| 124 | Pathogenesis of invasive candidiasis | 3.2 | 80 | Citations (PDF) |
| 125 | Activation of innate host defense mechanisms by Borrelia | 1.1 | 50 | Citations (PDF) |
| 126 | Mycoviruses: future therapeutic agents of invasive fungal infections in humans? | 2.6 | 47 | Citations (PDF) |
| 127 | The role of nurses in the recognition and treatment of patients with sepsis in the emergency department: A prospective before-and-after intervention study | 5.9 | 57 | Citations (PDF) |
| 128 | Novel strategies for the prevention and treatment ofCandidainfections: the potential of immunotherapy | 10.6 | 42 | Citations (PDF) |
| 129 | Differential susceptibility to lethal endotoxaemia in mice deficient in IL‐1α, IL‐1β or IL‐1 receptor type IApmis, 2010, 118, 1000-1007 | 2.5 | 28 | Citations (PDF) |
| 130 | Anti‐Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity | 4.7 | 124 | Citations (PDF) |
| 131 | Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency | 3.3 | 32 | Citations (PDF) |
| 132 | A Multifunctional Mannosyltransferase Family in Candida albicans Determines Cell Wall Mannan Structure and Host-Fungus Interactions | 2.2 | 118 | Citations (PDF) |
| 133 | Early Proinflammatory Cytokines and C‐Reactive Protein Trends as Predictors of Outcome in Invasive Aspergillosis | 3.7 | 62 | Citations (PDF) |
| 134 | Recognition ofBorrelia burgdorferiby NOD2 Is Central for the Induction of an Inflammatory Reaction | 3.7 | 72 | Citations (PDF) |
| 135 | Candida albicans
Releases Soluble Factors That Potentiate Cytokine Production by Human Cells through a Protease-Activated Receptor 1- and 2-Independent Pathway | 2.7 | 19 | Citations (PDF) |
| 136 | 18F-FDG PET/CT for Detection of Metastatic Infection in Gram-Positive Bacteremia | 5.1 | 138 | Citations (PDF) |
| 137 | The Candida Th17 response is dependent on mannan- and -glucan-induced prostaglandin E2 | 3.1 | 81 | Citations (PDF) |
| 138 | IL-1β Processing in Host Defense: Beyond the Inflammasomes | 4.4 | 465 | Citations (PDF) |
| 139 | Severe Candida spp. infections: new insights into natural immunity | 3.9 | 63 | Citations (PDF) |
| 140 | Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohorts | 6.0 | 75 | Citations (PDF) |
| 141 | Aspergillus fumigatus Conidial Melanin Modulates Host Cytokine Response | 1.1 | 132 | Citations (PDF) |
| 142 | The role of Toll-like receptors and C-type lectins for vaccination against Candida albicans | 3.1 | 40 | Citations (PDF) |
| 143 | Reactive oxygen species–independent activation of the IL-1β inflammasome in cells from patients with chronic granulomatous disease | 7.5 | 241 | Citations (PDF) |
| 144 | Bone-marrow uptake of 18F-FDG during fever | 16.5 | 6 | Citations (PDF) |
| 145 | Variable recognition ofCandida albicansstrains by TLR4 and lectin recognition receptors | 0.6 | 68 | Citations (PDF) |
| 146 | Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock | 7.5 | 90 | Citations (PDF) |
| 147 | Reply to Kontoyiannis | 5.2 | 3 | Citations (PDF) |
| 148 | Summary and comments | 3.1 | 0 | Citations (PDF) |
| 149 | Early Stop Polymorphism in Human DECTIN‐1 Is Associated with Increased
Candida
Colonization in Hematopoietic Stem Cell Transplant Recipients | 5.2 | 237 | Citations (PDF) |
| 150 | Modulation of Toll-Like Receptor 2 (TLR2) and TLR4 Responses byAspergillus fumigatus | 2.7 | 107 | Citations (PDF) |
| 151 | Receptor Recognition of and Immune Intracellular Pathways for
Veillonella parvula
Lipopolysaccharide | 3.1 | 66 | Citations (PDF) |
| 152 | Bypassing Pathogen‐Induced Inflammasome Activation for the Regulation of Interleukin‐1β Production by the Fungal PathogenCandida albicans | 3.7 | 72 | Citations (PDF) |
| 153 | Transcriptional and inflammasome‐mediated pathways for the induction of IL‐1β production by Mycobacterium tuberculosis | 3.1 | 79 | Citations (PDF) |
| 154 | Polymorphism in innate immunity genes and susceptibility to recurrent vulvovaginal candidiasis | 1.7 | 8 | Citations (PDF) |
| 155 | Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America | 5.2 | 2,742 | Citations (PDF) |
| 156 | The Macrophage Mannose Receptor Induces IL-17 in Response to Candida albicans | 15.1 | 312 | Citations (PDF) |
| 157 | Human Dectin-1 Deficiency and Mucocutaneous Fungal Infections | 34.5 | 723 | Citations (PDF) |
| 158 | Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophagesBlood, 2009, 113, 2324-2335 | 4.8 | 783 | Citations (PDF) |
| 159 | Fungal strategies for overcoming host innate immune response | 0.6 | 85 | Citations (PDF) |
| 160 | Cytokine production from stimulated whole blood cultures in rheumatoid arthritis patients treated with various TNF blocking agents | 1.1 | 17 | Citations (PDF) |
| 161 | Circulating Lipoproteins Are a Crucial Component of Host Defense against Invasive Salmonella typhimurium Infection | 2.3 | 27 | Citations (PDF) |
| 162 | Th17 responses and host defense against microorganisms: an overview | 3.0 | 95 | Citations (PDF) |
| 163 | Engagement of NOD2 has a dual effect on proIL‐1β mRNA transcription and secretion of bioactive IL‐1β | 3.1 | 70 | Citations (PDF) |
| 164 | Syk kinase is required for collaborative cytokine production induced through Dectin‐1 and Toll‐like receptors | 3.1 | 343 | Citations (PDF) |
| 165 | Role of TLR1 and TLR6 in the host defense against disseminated candidiasis | 3.0 | 89 | Citations (PDF) |
| 166 | Effects of Hydrophobicity on the Antifungal Activity of α‐Helical Antimicrobial Peptides | 3.1 | 84 | Citations (PDF) |
| 167 | Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus | 3.0 | 64 | Citations (PDF) |
| 168 | An integrated model of the recognition of Candida albicans by the innate immune system | 83.4 | 831 | Citations (PDF) |
| 169 | Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages | 1.6 | 321 | Citations (PDF) |
| 170 | Crohn’s disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 cross‐tolerance to intestinal stimuli | 4.7 | 56 | Citations (PDF) |
| 171 | Host–microbe interactions: innate pattern recognition of fungal pathogens | 7.0 | 152 | Citations (PDF) |
| 172 | Redundant role of TLR9 for anti-Candida host defense | 1.1 | 52 | Citations (PDF) |
| 173 | Aspergillus Attenuates Distinct Host TLR2 & TLR4 Responses | 2.1 | 0 | Citations (PDF) |
| 174 | Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group | 5.2 | 4,705 | Citations (PDF) |
| 175 | Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria | 5.2 | 450 | Citations (PDF) |
| 176 | Dendritic Cell Interaction with Candida albicans Critically Depends on N-Linked Mannan | 2.2 | 225 | Citations (PDF) |
| 177 | Drosomycin-Like Defensin, a Human Homologue of
Drosophila melanogaster
Drosomycin with Antifungal Activity | 4.1 | 38 | Citations (PDF) |
| 178 | Functional Consequences of Toll-like Receptor 4 Polymorphisms | 5.6 | 261 | Citations (PDF) |
| 179 | Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis | 5.2 | 156 | Citations (PDF) |
| 180 | Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment | 5.2 | 78 | Citations (PDF) |
| 181 | Treatment of knee prosthesis infections: evaluation of 15 patients over a 5-year period | 1.9 | 10 | Citations (PDF) |
| 182 | Immune Recognition ofCandida albicansβ‐glucan by Dectin‐1 | 3.7 | 305 | Citations (PDF) |
| 183 | Endoplasmic Reticulum α-Glycosidases of
Candida albicans
Are Required for N Glycosylation, Cell Wall Integrity, and Normal Host-Fungus Interaction | 2.7 | 139 | Citations (PDF) |
| 184 | TLR4
polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans | 7.5 | 310 | Citations (PDF) |
| 185 | Antibiotic Prophylaxis and the Risk of Surgical Site Infections following Total Hip Arthroplasty: Timely Administration Is the Most Important Factor | 5.2 | 266 | Citations (PDF) |
| 186 | Tailored Interventions to Improve Antibiotic Use for Lower Respiratory Tract Infections in Hospitals: A Cluster-Randomized, Controlled Trial | 5.2 | 75 | Citations (PDF) |
| 187 | Bartonella quintanaLipopolysaccharide Is a Natural Antagonist of Toll-Like Receptor 4 | 2.7 | 81 | Citations (PDF) |
| 188 | Mycobacterium paratuberculosisis recognized by Toll-like receptors and NOD2 | 2.9 | 137 | Citations (PDF) |
| 189 | Increased voluntary exercise in mice deficient for tumour necrosis factor‐α and lymphotoxin‐α | 3.0 | 13 | Citations (PDF) |
| 190 | Complicating infectious foci in patients with Staphylococcus aureus or Streptococcus species bacteraemia | 2.6 | 52 | Citations (PDF) |
| 191 | Toll-like receptor 2 controls expansion and function of regulatory T cells | 10.6 | 675 | Citations (PDF) |
| 192 | Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance | 33.0 | 403 | Citations (PDF) |
| 193 | Impaired dendritic cell function in Crohn’s disease patients with NOD2 3020insC mutation | 2.9 | 85 | Citations (PDF) |
| 194 | Endogenous Interleukin (IL)–1α and IL‐1β Are Crucial for Host Defense against Disseminated Candidiasis | 3.7 | 164 | Citations (PDF) |
| 195 | Host defence against disseminatedCandida albicansinfection and implications for antifungal immunotherapy | 3.0 | 50 | Citations (PDF) |
| 196 | Nucleotide Oligomerization Domain 2 (Nod2) Is Not Involved in the Pattern Recognition of
Candida albicans | 3.1 | 37 | Citations (PDF) |
| 197 | Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors | 10.6 | 687 | Citations (PDF) |
| 198 | Cytokine Responses to Fungal Pathogens in Kupffer Cells are Toll-like Receptor 4 Independent and Mediated by Tyrosine Kinases | 1.3 | 20 | Citations (PDF) |
| 199 | Severely impaired IL-12/IL-18/IFNgamma axis in patients with hyper IgE syndrome | 3.0 | 35 | Citations (PDF) |
| 200 | NOD2 and Toll-Like Receptors Are Nonredundant Recognition Systems of Mycobacterium tuberculosis | 4.4 | 324 | Citations (PDF) |
| 201 | Quality of Antibiotic Use for Lower Respiratory Tract Infections at Hospitals: (How) Can We Measure It? | 5.2 | 59 | Citations (PDF) |
| 202 | From the Th1/Th2 Paradigm towards a Toll-Like Receptor/T-Helper Bias | 4.1 | 177 | Citations (PDF) |
| 203 | Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis | 3.1 | 111 | Citations (PDF) |
| 204 | Influence of endogenous pro-inflammatory cytokines on neutrophil-mediated damage ofCandida albicanspseudohyphae, quantified in a modified tetrazolium dye assay | 0.6 | 11 | Citations (PDF) |
| 205 | Nucleotide-Binding Oligomerization Domain-2 Modulates Specific TLR Pathways for the Induction of Cytokine Release | 0.6 | 255 | Citations (PDF) |
| 206 | Effect of Recombinant Murine Granulocyte Colony-Stimulating Factor with or without Fluoroquinolone Therapy on Mixed-Infection Abscesses in Mice | 4.1 | 2 | Citations (PDF) |
| 207 | Differential Cytokine Production and Toll-Like Receptor Signaling Pathways by
Candida albicans
Blastoconidia and Hyphae | 2.7 | 183 | Citations (PDF) |
| 208 | Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial | 62.1 | 508 | Citations (PDF) |
| 209 | Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors | 3.1 | 47 | Citations (PDF) |
| 210 | Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy | 3.5 | 21 | Citations (PDF) |
| 211 | Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism | 3.5 | 59 | Citations (PDF) |
| 212 | Response to Gil et al.: Toll-like receptor-2 – an important component of host defense | 8.1 | 4 | Citations (PDF) |
| 213 | Cytokine responses and regulation of interferon-gamma release by human mononuclear cells toAspergillus fumigatusand other filamentous fungi | 0.6 | 62 | Citations (PDF) |
| 214 | Design of Efficacy Trials of Cytokines in Combination with Antifungal Drugs | 5.2 | 36 | Citations (PDF) |
| 215 | Detection of the
Candida
Antigen Mannan in Cerebrospinal Fluid Specimens from Patients Suspected of Having
Candida
Meningitis | 4.0 | 52 | Citations (PDF) |
| 216 | Two Patients with Cryptococcal Meningitis and Idiopathic CD4 Lymphopenia: Defective Cytokine Production and Reversal by Recombinant Interferon- Therapy | 5.2 | 96 | Citations (PDF) |
| 217 | Recombinant Interleukin‐18 Protects against DisseminatedCandida albicansInfection in Mice | 3.7 | 32 | Citations (PDF) |
| 218 | Apolipoprotein-E-deficient mice exhibit an increased susceptibility to disseminated candidiasis | 0.6 | 36 | Citations (PDF) |
| 219 | Improving the Process of Antibiotic Therapy in Daily Practice | 8.1 | 38 | Citations (PDF) |
| 220 | Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia | 3.0 | 68 | Citations (PDF) |
| 221 | Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolemia. European Journal of Clinical Investigation 2004;34:94-99 | 3.0 | 0 | Citations (PDF) |
| 222 | Acute disseminated encephalomyelitis associated with Borrelia burgdorferi | 3.4 | 16 | Citations (PDF) |
| 223 | Recognition of fungal pathogens by Toll-like receptors | 2.6 | 133 | Citations (PDF) |
| 224 | NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease | 3.1 | 214 | Citations (PDF) |
| 225 | Human dendritic cells are less potent at killing Candida albicans than both monocytes and macrophages | 2.4 | 57 | Citations (PDF) |
| 226 | Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system | 2.9 | 260 | Citations (PDF) |
| 227 | An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis | 4.9 | 41 | Citations (PDF) |
| 228 | Toll-like receptors as an escape mechanism from the host defense | 8.1 | 205 | Citations (PDF) |
| 229 | Duration of Antifungal Treatment and Development of Delayed Complications in Patients with Candidaemia | 2.6 | 44 | Citations (PDF) |
| 230 | Voriconazole Salvage Treatment of Invasive Candidiasis | 2.6 | 120 | Citations (PDF) |
| 231 | The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells | 3.1 | 353 | Citations (PDF) |
| 232 | Differential role of IL-18 and IL-12 in the host defense against disseminatedCandida albicans infection | 3.1 | 56 | Citations (PDF) |
| 233 | Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: Association with decreased interferon-? production and toll-like receptor 4 expression | 6.1 | 116 | Citations (PDF) |
| 234 | Selecting outcome parameters in studies aimed at improving rational use of antibiotics - practical considerations | 1.8 | 4 | Citations (PDF) |
| 235 | Selective regulation of intercellular adhesion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes | 4.7 | 55 | Citations (PDF) |
| 236 | Two cases of subcutaneous Scedosporium apiospermum infection treated with voriconazole | 5.3 | 35 | Citations (PDF) |
| 237 | Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing? | 10.4 | 177 | Citations (PDF) |
| 238 | Regulation of Staphylococcus epidermidis-induced IFN-γ in whole human blood: the role of endogenous IL-18, IL-12, IL-1, and TNF | 3.5 | 24 | Citations (PDF) |
| 239 | Adherence to local hospital guidelines for surgical antimicrobial prophylaxis: a multicentre audit in Dutch hospitals | 3.1 | 131 | Citations (PDF) |
| 240 | Treatment of Intra-Abdominal Abscesses Caused by
Candida albicans with Antifungal Agents and Recombinant Murine
Granulocyte Colony-Stimulating
Factor | 4.1 | 8 | Citations (PDF) |
| 241 | Aspergillus fumigatusEvades Immune Recognition during Germination through Loss of Toll‐Like Receptor‐4–Mediated Signal Transduction | 3.7 | 294 | Citations (PDF) |
| 242 | Cytokine Release in Healthy Donors and Patients with Chronic Granulomatous Disease upon Stimulation with Aspergillus fumigatus | 1.5 | 46 | Citations (PDF) |
| 243 | The Role of Toll‐like Receptor (TLR) 2 and TLR4 in the Host Defense against Disseminated Candidiasis | 3.7 | 471 | Citations (PDF) |
| 244 | Parenteral Administration of Medium- but Not Long-Chain Lipid Emulsions May Increase the Risk for Infections by
Candida albicans | 2.7 | 25 | Citations (PDF) |
| 245 | Reply | 3.7 | 0 | Citations (PDF) |
| 246 | The Role of Endogenous Interleukin (IL)–18, IL‐12, IL‐1β, and Tumor Necrosis Factor–α in the Production of Interferon‐γ Induced byCandida albicansin Human Whole‐Blood Cultures | 3.7 | 68 | Citations (PDF) |
| 247 | Delayed Clearance of Intraabdominal Abscesses Caused byCandida albicansin Tumor Necrosis Factor–α– and Lymphotoxin‐α–Deficient Mice | 3.7 | 32 | Citations (PDF) |
| 248 | Native LDL potentiate TNFα and IL-8 production by human mononuclear cells | 3.6 | 15 | Citations (PDF) |
| 249 | Role of Interleukin-18 in Host Defense against Disseminated
Candida albicans
Infection | 2.7 | 51 | Citations (PDF) |
| 250 | Improved Survival of TNF-Deficient Mice During the Zymosan-Induced Multiple Organ Dysfunction Syndrome | 2.4 | 45 | Citations (PDF) |
| 251 | Phagocytosis and intracellular killing of Candida albicans blastoconidia by neutrophils and macrophages: a comparison of different microbiological test systems | 1.7 | 60 | Citations (PDF) |
| 252 | Deeply invasive candidiasis | 3.1 | 57 | Citations (PDF) |
| 253 | Non-LPS components ofChlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways | 3.1 | 103 | Citations (PDF) |
| 254 | CD40/CD40 ligand interactions in the host defense against disseminated Candida albicans infection: the role of macrophage-derived nitric oxide | 3.1 | 53 | Citations (PDF) |
| 255 | Failure of prescribers to adjust antibiotic dose to impaired renal function in daily clinical practice | 2.5 | 0 | Citations (PDF) |
| 256 | Use of fluconazole in daily practice: still room for improvement | 3.1 | 15 | Citations (PDF) |
| 257 | The Impact of Nontuberculous Myobacteria on Management of Presumed Pulmonary Tuberculosis | 2.9 | 20 | Citations (PDF) |
| 258 | Pro-inflammatory cytokines in patients with essential hypertension | 3.0 | 130 | Citations (PDF) |
| 259 | LethalEscherichia coli andSalmonella typhimurium endotoxemia is mediated through different pathways | 3.1 | 42 | Citations (PDF) |
| 260 | Differential Roles of Interleukin-18 (IL-18) and IL-12 for Induction of Gamma Interferon by Staphylococcal Cell Wall Components and Superantigens | 2.7 | 26 | Citations (PDF) |
| 261 | Acellular components ofChlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells | 3.1 | 93 | Citations (PDF) |
| 262 | Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1β | 3.1 | 117 | Citations (PDF) |
| 263 | Apolipoprotein E-deficient mice have an impaired immune response toKlebsiella pneumoniae | 3.0 | 70 | Citations (PDF) |
| 264 | Circulating Cytokines as Mediators of Fever | 5.2 | 321 | Citations (PDF) |
| 265 | Earlier Initiation of Antibiotic Treatment for Severe Infections After Interventions to Improve the Organization and Specific Guidelines in the Emergency Department | 8.1 | 23 | Citations (PDF) |
| 266 | Combined treatment: antifungal drugs with antibodies, cytokines or drugs | 0.6 | 44 | Citations (PDF) |
| 267 | Selective digestive decontamination in patients in intensive care | 3.1 | 77 | Citations (PDF) |
| 268 | Oxidation of Low‐Density Lipoproteins by Acellular Components ofChlamydia pneumoniae | 3.7 | 10 | Citations (PDF) |
| 269 | Reply | 3.7 | 0 | Citations (PDF) |
| 270 | Cervical Spinal Epidural Abscess Due to Group B Streptococcus in a Previously Healthy Elderly Male | 1.5 | 8 | Citations (PDF) |
| 271 | Increased Production of Interleukin 4 by CD4 + and CD8 + T Cells from Patients with Tuberculosis Is Related to the Presence of Pulmonary Cavities | 3.7 | 186 | Citations (PDF) |
| 272 | Title is missing! 2000 | | 2 | Citations (PDF) |
| 273 | Combined treatment: antifungal drugs with antibodies, cytokines or drugs | 0.6 | 0 | Citations (PDF) |
| 274 | Combined treatment: antifungal drugs with antibodies, cytokines or drugs | 0.6 | 0 | Citations (PDF) |
| 275 | Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice 1 | 0.6 | 72 | Citations (PDF) |
| 276 | Treatment of Fungal Infections in Surgical Patients Using Conventional Antifungals | 1.5 | 5 | Citations (PDF) |
| 277 | Modulation of the Pro‐ and Antiinflammatory Cytokines by Amphotericin B | 3.7 | 3 | Citations (PDF) |
| 278 | Fas‐FasL Interactions Modulate Host Defense against SystemicCandida albicansInfection | 3.7 | 19 | Citations (PDF) |
| 279 | Infusion of Lipoproteins into Volunteers Enhances the Growth of Candida albicans | 5.2 | 17 | Citations (PDF) |
| 280 | Do only circulating pyrogenic cytokines act as mediators in the febrile response? A hypothesis | 3.0 | 20 | Citations (PDF) |
| 281 | Modulation of neutrophil function in host defense against disseminatedCandida albicansinfection in mice | 3.0 | 59 | Citations (PDF) |
| 282 | Disease-specific ex vivo stimulation of whole blood for cytokine production: applications in the study of tuberculosis | 1.4 | 45 | Citations (PDF) |
| 283 | Therapy of invasive fungal infections | 0.9 | 16 | Citations (PDF) |
| 284 | Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection | 1.5 | 7 | Citations (PDF) |
| 285 | Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection | 3.6 | 191 | Citations (PDF) |
| 286 | Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice 1 | 0.6 | 10 | Citations (PDF) |
| 287 | Aspergillus
Meningitis: Diagnosis by Non-Culture-Based Microbiological Methods and Management | 4.0 | 140 | Citations (PDF) |
| 288 | Soluble Murine IL-1 Receptor Type I Induces Release of Constitutive IL-1α | 0.6 | 13 | Citations (PDF) |
| 289 | Proinflammatory Cytokines and Treatment of Disease | 4.0 | 28 | Citations (PDF) |
| 290 | Delay in Administering the First Dose of Antibiotics in Patients Admitted to Hospital with Serious Infections | 2.6 | 42 | Citations (PDF) |
| 291 | The effect of renin–angiotensin system inhibitors on pro‐ and anti‐inflammatory cytokine production | 4.7 | 97 | Citations (PDF) |
| 292 | Lipopolysaccharide‐induced production of tumour necrosis factor and interleukin‐1 is differentially regulated at the receptor level: the role of CD14‐dependent and CD14‐independent pathways | 4.7 | 26 | Citations (PDF) |
| 293 | Cytokines as therapy for opportunistic fungal infections | 0.8 | 31 | Citations (PDF) |
| 294 | BACTERIAL LIPOPOLYSACCHARIDE BINDS AND STIMULATES CYTOKINE-PRODUCING CELLS BEFORE NEUTRALIZATION BY ENDOGENOUS LIPOPROTEINS CAN OCCUR | 3.5 | 60 | Citations (PDF) |
| 295 | LPS-induced cytokine production and expression of β2-integrins and CD14 by peripheral blood mononuclear cells of patients with homozygous familial hypercholesterolemia | 1.5 | 33 | Citations (PDF) |
| 296 | Recombinant Murine Granulocyte Colony‐Stimulating Factor Protects against Acute DisseminatedCandida albicansInfection in Nonneutropenic Mice | 3.7 | 57 | Citations (PDF) |
| 297 | Microgranulomatous Aspergillosis in a Patient with Chronic Granulomatous Disease: Cure with Voriconazole | 5.2 | 23 | Citations (PDF) |
| 298 | Pathogenesis of Fever: Are Circulating Pyrogenic Cytokines the Only Mediators? | 5.2 | 2 | Citations (PDF) |
| 299 | Modulation of the pro- and anti-inflammatory cytokine balance by amphotericin B | 3.1 | 39 | Citations (PDF) |
| 300 | Guidelines for the Prevention of Antimicrobial Resistance in Hospitals | 5.2 | 12 | Citations (PDF) |
| 301 | Lipoprotein(a) Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Production by Human Mononuclear Cells | 2.7 | 27 | Citations (PDF) |
| 302 | REGULATION OF THE PRODUCTION OF PRO-INFLAMMATORY CYTOKINES AND ANTAGONISTS DURING CHEMOTHERAPY-INDUCED NEUTROPENIA IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES | 3.5 | 17 | Citations (PDF) |
| 303 | The Role of Hyperuricemia in the Increased Cytokine Production After Lipopolysaccharide Challenge in Neutropenic Mice | 4.8 | 135 | Citations (PDF) |
| 304 | Trends in immunotherapy of fungal infections | 2.6 | 62 | Citations (PDF) |
| 305 | The effects of dexamethasone and chlorpromazine on tumour necrosis factor‐
α
, interleukin‐1
β
, interleukin‐1 receptor antagonist and interleukin‐10 in human volunteers | 4.7 | 37 | Citations (PDF) |
| 306 | Helicobacter cinaedi Bacteremia Associated with Localized Pain but Not with Cellulitis | 5.2 | 27 | Citations (PDF) |
| 307 | Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. | 10.6 | 202 | Citations (PDF) |
| 308 | An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy | 1.5 | 36 | Citations (PDF) |
| 309 | Phospholipase A2 Is a Circulating Mediator in Typhoid Fever | 3.7 | 27 | Citations (PDF) |
| 310 | Pharmacologic Inhibitors of Tumor Necrosis Factor Production Exert Differential Effects in Lethal Endotoxemia and in Infection with Live Microorganisms in Mice | 3.7 | 74 | Citations (PDF) |
| 311 | Interleukin-1 and related pro-inflammatory cytokines in the treatment of bacterial infections in neutropenic and non-neutropenic animals | 0.8 | 10 | Citations (PDF) |
| 312 | Cytokines in the treatment of fungal infections | 0.8 | 16 | Citations (PDF) |
| 313 | Amphotericin B versus amphotericin B plus 5-flucytosine: Poor results in the treatment of proven systemic mycoses in neutropenic patients | 2.9 | 54 | Citations (PDF) |
| 314 | Severe osteomyelitis due to the zygomycete Apophysomyces elegans | 4.0 | 65 | Citations (PDF) |
| 315 | Recombinant Interferon- Enhances Resistance to Acute Disseminated Candida albicans Infection in Mice | 3.7 | 149 | Citations (PDF) |
| 316 | Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in neutropenic mice | 4.1 | 30 | Citations (PDF) |
| 317 | Optimizing antimicrobial therapy. A method for antimicrobial drug me evaluation | 3.1 | 91 | Citations (PDF) |
| 318 | Purpura Fulminans and Symmetrical Peripheral Gangrene Caused by Capnocytophaga canimorsus (Formerly DF-2) Septicemia—A Complication of Dog Bite | 1.2 | 124 | Citations (PDF) |
| 319 | Evaluation of cloxacillin concentrations in plasma and muscle tissue during cardiopulmonary bypass | 1.5 | 6 | Citations (PDF) |
| 320 | No effect of recombinant human interleukin-1 on numbers of peripheral blood and peritoneal leukocytes during acute inflammation | 4.0 | 17 | Citations (PDF) |
| 321 | Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1 | 2.7 | 109 | Citations (PDF) |
| 322 | Legionella infection with acute renal failure and thrombocytopenia mimicking allograft rejection: A pitfall in post-transplantation diagnosis | 2.0 | 6 | Citations (PDF) |
| 323 | Lyme borreliosis: diagnosis and management | 0.2 | 123 | Citations (PDF) |
| 324 | Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis: Results from the Double-blind, Randomized, Phase 3 ReSTORE Trial Including the China Extension Study | 0.8 | 3 | Citations (PDF) |
